Please check your internet connection and try again.
# Miconazole Vaginal Pessary
## Overview
Miconazole is an imidazole antifungal agent. It is used to treat vaginal yeast infections (vulvovaginal candidiasis).
## Primary Indications
* Treatment of vulvovaginal candidiasis (yeast infection).
## Adult Dosing
* **Single-dose treatment:** One (1) miconazole vaginal 1200 mg pessary inserted vaginally at bedtime.
* **Three-day treatment:** One (1) miconazole vaginal 200 mg pessary inserted vaginally at bedtime for 3 consecutive nights.
* **Seven-day treatment:** One (1) miconazole vaginal 100 mg pessary inserted vaginally at bedtime for 7 consecutive nights.
The choice of regimen depends on patient preference and severity of infection.
## Pediatric Dosing
* **Children 12 years and older:** Dosing is the same as for adults.
* **Children younger than 12 years:** Safety and efficacy have not been established. Use with caution and consider alternative treatments if available.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment with vaginal administration.
## Contraindications
* Hypersensitivity to miconazole or any component of the formulation.
* Concomitant use with warfarin. Miconazole can significantly increase warfarin levels, leading to bleeding.
## Adverse Effects
* **Common:** Vaginal burning, itching, irritation, pelvic cramping.
* **Less Common:** Headache, vulvar/vaginal swelling, rash.
## Key Drug Interactions
* **Warfarin:** Miconazole (especially oral or high-dose vaginal) can inhibit CYP2C9, increasing warfarin levels and the risk of bleeding. Close monitoring of INR is crucial if co-administration is unavoidable.
## Monitoring
* Monitor for improvement of symptoms (itching, burning, discharge).
* Monitor for signs of local irritation or allergic reaction.
* If using with warfarin, monitor INR closely.
## Clinical Pearls
* Pessaries are for vaginal use only.
* Complete the full course of treatment as prescribed, even if symptoms improve earlier.
* Avoid intercourse during treatment as the pessary may interact with latex condoms or diaphragms, reducing their effectiveness.
* If symptoms persist after completing treatment, or if recurrence occurs, re-evaluate for resistant organisms or consider alternative therapies.
***
*This information is intended for clinical decision-making and does not replace the need to consult the official prescribing information or other authoritative sources. Always verify current dosing and safety information before use.*
